.- The
Grünenthal laboratory, which manufactures the morning-after pill in
Chile, has decided to pull the drug from the market because of poor
sales and the constant legal challenges being made by pro-life groups
who denounce the drug’s abortifacient nature.
Pro-life
leaders, represented by Fernanda Otero, applauded the decision, saying
it “proves that [the drug] induces an abortion.” “Life must
always be protected,” she said, adding she was sure the drug was going
to be pulled because nobody can guarantee that it “does not kill the
unborn.”
On the other
side, Veronica Schiappacasse, a researcher at the Chilean Institute of
Reproductive Medicine and a fervent supporter of the drug, said the
decision by Grünenthal was “troubling and understandable.” “I
suppose they had no intention of continuing to manufacture it as it was
not good business.”
Schiappacasse
said she would now look to the new government led by President Michelle
Bachelet “to create policies in favor of women’s rights and not be
pressured by minority groups that want to control the rights of
Chileans.”
Poor sales force laboratory to pull morning-after pill from Chilean market
Related news
Related articles
* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages
Featured Videos
May
19
Catholic Daily
Gospel of the Day
John 20,19-23
Gospel
Date
05/19/13
05/18/13
05/17/13
Daily Readings
First Reading:: Acts 2:1-11Second Reading:: 1 Cor 12:3b-7, 12-13Gospel:: Jn 20:19-23Homily of the Day
John 20,19-23
Homily
Date
05/19/13
05/18/13
05/17/13
Most Popular
Ads by AdsLiveMedia.com
